Remission of a primary thyroid lymphoma after methotrexate withdrawal.
de Mast
Quirijn
Q
Haverman
Joost
J
Netten
Paetrick M
PM
Sinnige
Harm A M
HA
D000368:Aged; D018501:Antirheumatic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D005260:Female; D050031:Hashimoto Disease / Q000188:drug therapy; D006801:Humans; D016393:Lymphoma, B-Cell / Q000139:chemically induced / Q000503:physiopathology*; D008727:Methotrexate / Q000008:administration & dosage* / Q000009:adverse effects; D012075:Remission, Spontaneous; D013964:Thyroid Neoplasms / Q000139:chemically induced / Q000503:physiopathology*; D013974:Thyroxine / Q000627:therapeutic use
D018501:Antirheumatic Agents; D013974:Thyroxine; D008727:Methotrexate